Choosing a concomitant chemotherapy and radiotherapy regimen for squamous cell head and neck cancer: A systematic review of the published literature with subgroup analysis

Head and Neck

Volumn 23, Issue 7, 2001, Pages 579-589

  Browman, George P ^a   Ian Hodson, D ^a   Mackenzie, Robert J ^a   Bestic, Nancy ^a   Zuraw, Lisa ^a  

^a CANCER CARE ONTARIO   (Canada)

Author keywords

Chemotherapy; Concomitant therapy; Head and neck neoplasms; Radiotherapy; Systematic review

Indexed keywords

BLEOMYCIN; CARBOPLATIN; CYCLOPHOSPHAMIDE; DICOUMAROL; FLUOROURACIL; FOLINIC ACID; HYDROXYUREA; METHOTREXATE; MITOMYCIN C; PLATINUM DERIVATIVE;

ADVANCED CANCER; BLOOD TOXICITY; BODY WEIGHT DISORDER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG INFUSION; HEAD AND NECK CANCER; HUMAN; META ANALYSIS; MORTALITY; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; RADIATION INJURY; RANDOMIZED CONTROLLED TRIAL; REVIEW; SQUAMOUS CELL CARCINOMA; STOMATITIS; WEIGHT REDUCTION;

CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; HEAD AND NECK NEOPLASMS; HUMANS; RANDOMIZED CONTROLLED TRIALS;

EID: 0034975986     PISSN: 10433074     EISSN: None     Source Type: Journal    
DOI: 10.1002/hed.1081     Document Type: Review

References (51)

1. Head and neck cancer
2. Controversies in patient management: Evidence-based recommendations against neoadjuvant chemotherapy for routine management of patients with squamous cell head and neck cancer
3. Adjuvant chemotherapy in head and neck cancer
4. An overview of randomized controlled trials of adjuvant chemotherapy in head and neck cancer
5. Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region: A meta-analysis of prospective and randomized trials
6. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: Three meta-analyses of updated individual data
7. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer
8. Larynx preservation in pyriform sinus cancer: Preliminary results of a European Organization for Research and Treatment of Cancer phase III trial
9. Hyperfractionated radiotherapy of human tumors: Overview of the randomized trials
10. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: First report of RTOG 9003
11. Meta-analysis in clinical trials
12. Radiation alone versus radiation with weekly low dose cis-platinum in unresectable cancer of the head and neck
13. Controlled trials of synchronous chemotherapy with radiotherapy in head and neck cancer: Overview of radiation morbidity
14. Combined therapy in advanced head and neck cancer: Hydroxyuea and radiotherapy
15. Combined radiation therapy and 5 fluorouracil for advanced squamous cell carcinoma of the oral cavity and oropharynx: A randomized study
16. Combined preoperative treatment with cobalt and bleomycin in patients with head and neck carcinoma: A controlled clinical study
17. Combined use of bleomycin with radiation in the treatment of cancer: Antitumour antibiotics
18. Hydroxyurea and radiotherapy in head and neck cancer: Long term results of a double blind randomized prospective study
19. Combined bleomycin and radiotherapy in oral cancer
20. Clinical significance of radiation therapy combined with chemotherapy
21. Treatment of advanced head and neck cancer: Multiple daily dose fractionated radiation therapy and sequential multimodal treatment approach
22. Combined bleomycin treatment and radiation therapy in squamous cell carcinoma of the head and neck region
23. Bleomycin and radiation therapy in squamous cell carcinoma of the upper aero-digestive tract: A phase III clinical trial
24. Controlled study in squamous cell carcinoma of base of tongue using conventional radiation, radiation with single drug and radiation with multiple drug chemotherapy
25. A randomized clinical trial to contrast radiotherapy with radiotherapy and methotrexate given synchronously in head and neck cancer
26. Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer: Update of a Northern California Oncology Group randomized trial
27. Ten-year results of randomized trial comparing radiotherapy and concomitant bleomycin to radiotherapy alone in epidermoid carcinomas of the oropharynx: Experience of the European Organization for Research and Treatment of Cancer
28. Randomized clinical trial of mitomycin C as an adjunct to radiotherapy in head and neck cancer
29. Mitomycin C as an adjunct to postoperative radiation therapy in squamous cell carcinoma of the head and neck: Results from two randomized clinical trials
30. Chemotherapy as an adjunct to radiation in the treatment of squamous cell carcinoma of the head and neck: Results of the Yale mitomycin C randomized trials
31. Single fraction per day versus two fractions per day versus radiochemotherapy in the treatment of head and neck cancer
32. Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced squamous cell carcinoma of the head and neck: Preliminary report of a randomized trial
33. A randomized trial of neoadjuvant vs concomitant chemotherapy vs radiotherapy alone in the treatment of stage IV head and neck squamous cell carcinoma
34. Simultaneous chemoradiation in the treatment of advanced head and neck cancer
35. Treatment of advanced squamous-cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy
36. Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck
37. A randomized trial of radiation therapy compared to split course radiation therapy combined with mitomycin C and 5 fluorouracil as initial treatment for advanced laryngeal and hypopharyngeal squamous carcinoma
38. Placebo-controlled randomized trial of infusional fluorouracil during standard radiotherapy in locally advanced head and neck cancer
39. Radiotherapy, combined with simultaneous chemotherapy with mitomycin C and bleomycin for inoperable head and neck cancer: Preliminary report
40. Concomitant radiotherapy with mitomycin C and bleomycin compared with radiotherapy alone in inoperable head and neck cancer: Final report
41. Radiation therapy alone or with concurrent low-dose daily either cisplatin or carboplatin in locally advanced unresectable squamous cell carcinoma of the head and neck: A prospective randomized trial
42. A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer: Preliminary results
43. Management of the neck in a randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer
44. Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: A randomized multicenter study
45. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer
46. Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancer
47. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma
48. Preliminary results of a randomized EORTC study comparing radiotherapy and concurrent bleomycin to radiotherapy alone in epidermoid carcinoma of the oropharynx
49. Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: A prospective randomized trial
50. The practice guidelines development cycle: A conceptual tool for practice guidelines development and implementation
51. Progress of clinical oncology guidelines development using the practice guidelines development cycle: The role of practitioner feedback